Target intelligence / Profile preview

Melanocyte-mediated repigmentation

Molecular classification
Other (cellular process involving multiple molecular targets), Key molecular targets involved: Melanocyte stem cell (McSC), Microphthalmia-associated transcription factor (MITF), Melanocortin 1 receptor (MC1R), Wnt/β-catenin pathway, cAMP pathway
01

Overview

Melanocyte-mediated repigmentation refers to the restoration of skin color through the activation, migration, proliferation, and differentiation of melanocytes, typically in hair-bearing areas where melanocyte precursors reside in the hair follicle bulge and infundibulum. The process is triggered by UV light, immunosuppressive drugs, and other stimuli, resulting in new melanocytes repopulating areas depleted due to autoimmune attack (as in vitiligo). Key molecular regulators include MITF, MC1R, and Wnt/β-catenin signaling; therapeutic approaches target these pathways and the immune response to facilitate repigmentation.

Other names
Melanocyte repopulationMelanocyte RestorationRepigmentation in vitiligoEpidermal repigmentation
02

Mechanism of action

Activation of melanocyte stem cells or precursors Migration and differentiation into mature melanocytes Restoration of pigment via reactivation of melanogenic pathways, including MITF signaling and MC1R activation Immunosuppression to halt autoimmune attack against melanocytes (e.g. by JAK inhibitors or corticosteroids)

03

Biological functions

Cell migrationCell proliferationCell differentiation (melanocyte maturation)Melanin synthesisSkin pigmentation
04

Disease associations

VitiligoAutoimmune skin depigmentationHypopigmentation disorders
05

Safety considerations

Local and systemic immunosuppression (infection risk with corticosteroids, calcineurin inhibitors, JAK inhibitors)Poor response in areas lacking hair follicles or with ongoing active immune destruction
06

Interacting drugs

Corticosteroids (topical/systemic)

4 more in the full profile.

07

Biomarkers

Presence of functioning hair follicles (perifollicular repigmentation)Expression of melanocyte antigens (e.g. MART-1/Melan-A, TYR)MITF expression

Beyond the preview

Go deeper on Melanocyte-mediated repigmentation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Melanocyte-mediated repigmentation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call